Avastin macular degeneration treatment

Avastin eye injection is a treatment for macular degeneration and other eye diseases



Avastin treatment for macular degeneration

Macular degeneration is the leading cause of blindness in people over the age of 50. Avastin can slow or stop vision robbing leaking and swelling (wet macular degeneration) in the retina.

The macula is the highly sensitive part of the retina, on the back of your eye. Vision works like the film in a camera by picking up the picture being focused by your cornea and eye’s lens. Macular degeneration occurs when there is a breakdown of the macula, in the central portion of the retina. Since the macula is responsible for the fine central vision in the eye that is needed for driving a car, reading fine print, recognizing faces, etc., central blindness can occur.

There are two types of macular degeneration: dry and wet macular degeneration. In the wet form of AMD, abnormal blood vessels grow in the back of the eye. Sometimes these vessels leak blood or fluid that causes blurred vision or distorted vision. Without treatment, vision loss may be quick and severe.
the patient should consult their retina specialist / ophthalmologist about signs and symptoms of Avastin side effects.
Avastin is an eye injection drug given by an eye surgeon. It is better and more effective than traditional laser eye surgery because it does not leave scarring in the macular central portion of vision.

Avastin was developed by Genentech for colorectal cancer and is not FDA approved for ARMD, although it is widely used for wet macular degeneration.

Avastin side effects

For the Avastin dose recommended for colorectal cancer, there are many possible side effects. Avastin for treatment of macular degeneration however, there are very few and rare side effects. The possibility of infection is extremely important to understand and the patient should consult their retina specialist / ophthalmologist about signs and symptoms of Avastin side effects.

Avastin eye injection uses

Avastin has also been approved for the treatment of diabetic macular edema and retinal vein occlusion.



by Mark Erickson

Working as an Ophthalmic Photographer since 1988, Mark Erickson has examined and photographed virtually every type of eye condition there is through various high-powered microscopes and cameras. This experience has given him a unique and intimate understanding of the eye and its various anatomical structures, diseases and surgical procedures. In 1998, Mark started coupling this medical photography experience with his artistic and creative abilities. The result is a vast gallery of various eye anatomy, eye conditions & diseases and surgical illustrations. Mark’s work has been published on the front cover of numerous, top eye care industry magazines and books. His work frequently illustrates the front cover of industry journals. Mark’s work has been commissioned by National Geographic, Bausch & Lomb, Johnson & Johnson and Transition Lenses, to name a few. Mark Erickson’s artwork and story were published in The National Association of Photoshop Professionals monthly publication, “Photoshop User” and “Layers” magazines. Mark now focuses his creative energy on his website, JirehDesign.com, and creating and licensing stock and custom ophthalmic illustrations and animations for use in pharmaceutical marketing, legal cases, product marketing, websites and patient education materials.